Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Falkenstein

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
European Journal of Clinical Nutrition|November 27, 2021
Correction: Short-term effects of carbohydrates differing in glycemic index (GI) consumed at lunch on children's cognitive function in a randomized crossover studyKathrin Jansen, Jana Tempes, Alina Drozdowska, et al.
Scientific Reports|February 10, 2015
Handedness and the X chromosome: the role of androgen receptor CAG-repeat lengthLarissa Arning, Sebastian Ocklenburg, Stefanie Schulz, et al.
Plos One|July 5, 2013
PCSK6 VNTR Polymorphism Is Associated with Degree of Handedness but Not Direction of HandednessLarissa Arning, Sebastian Ocklenburg, Stefanie Schulz, et al.
International Journal of Cancer|July 4, 2017
Cyclin K dependent regulation of Aurora B affects apoptosis and proliferation by induction of mitotic catastrophe in prostate cancerSabrina Schecher, Britta Walter, Michael Falkenstein, et al.
Urologic Oncology|June 12, 2018
FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancerCarine Pecqueux, Aysenur Arslan, Martina Heller, et al.
Oncotarget|July 25, 2016
Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progressionJulia M A Pickl, Diana Tichy, Vladimir Y Kuryshev, et al.
Urologic Oncology|July 18, 2020
Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53Adam Kaczorowski, Yanis Tolstov, Michael Falkenstein, et al.
Urologic Oncology|December 5, 2017
Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapyXin Chen, Christof Bernemann, Yuri Tolkach, et al.
Archives of Toxicology|April 26, 2012
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer riskSilvia Selinski, Marie-Louise Lehmann, Meinolf Blaszkewicz, et al.
Pharmacogenetics and Genomics|July 14, 2011
Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotypeSilvia Selinski, Meinolf Blaszkewicz, Marie-Louise Lehmann, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
European Journal of Clinical Nutrition|November 27, 2021
Correction: Short-term effects of carbohydrates differing in glycemic index (GI) consumed at lunch on children's cognitive function in a randomized crossover studyKathrin Jansen, Jana Tempes, Alina Drozdowska, et al.
Scientific Reports|February 10, 2015
Handedness and the X chromosome: the role of androgen receptor CAG-repeat lengthLarissa Arning, Sebastian Ocklenburg, Stefanie Schulz, et al.
Plos One|July 5, 2013
PCSK6 VNTR Polymorphism Is Associated with Degree of Handedness but Not Direction of HandednessLarissa Arning, Sebastian Ocklenburg, Stefanie Schulz, et al.
International Journal of Cancer|July 4, 2017
Cyclin K dependent regulation of Aurora B affects apoptosis and proliferation by induction of mitotic catastrophe in prostate cancerSabrina Schecher, Britta Walter, Michael Falkenstein, et al.
Urologic Oncology|June 12, 2018
FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancerCarine Pecqueux, Aysenur Arslan, Martina Heller, et al.
Oncotarget|July 25, 2016
Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progressionJulia M A Pickl, Diana Tichy, Vladimir Y Kuryshev, et al.
Urologic Oncology|July 18, 2020
Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53Adam Kaczorowski, Yanis Tolstov, Michael Falkenstein, et al.
Urologic Oncology|December 5, 2017
Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapyXin Chen, Christof Bernemann, Yuri Tolkach, et al.
Archives of Toxicology|April 26, 2012
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer riskSilvia Selinski, Marie-Louise Lehmann, Meinolf Blaszkewicz, et al.
Pharmacogenetics and Genomics|July 14, 2011
Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotypeSilvia Selinski, Meinolf Blaszkewicz, Marie-Louise Lehmann, et al.
Pageof 15